After two days of declines, shares of Bright Minds Biosciences (NASDAQ:DRUG) bounced back in the premarket on Friday with a ~48% rise after the psychedelic drug developer announced a private ...

Shares of Bright Minds Biosciences on Friday shot higher after pricing a $35 million private placement. The stock was up 70% at $36.86 in pre-market trading. The company said it has priced the ...

Bright Minds Biosciences announced a non-brokered private placement with expected gross proceeds of $35 million. The company's stock is currently trading with a session volume of about 10.6 million.

VANCOUVER, British Columbia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) is pleased to announce a non ...

Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped more than 100% in early-morning trading Friday after the psychedelic drug developer announced a $35 million private placement, capping a week ...

The Northern Territory has passed new laws that lower the age of criminal responsibility to 10, about two years after the previous government raised the age to 12. It comes a day after the Country ...

or other clear violations of federal criminal statutes). Illegal activity is anything Trump disapproves of or finds harmful: criticizing pro-Trump judges, displaying too many news stories that ...

‘She’s a criminal. She’s a criminal,’ said Trump. ... ‘She really is, if you think about it.’ So let me get this straight. As recently as May, a jury found Trump guilty of 34 felonie ...

Bright Minds' drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating ...

Bright Minds says nothing has material has changed in response to the stock move. Psychedelic drug company Bright Minds Biosciences Inc. (NASDAQ: DRUG) saw its stock rocket higher by 1,445% to close ...